Rare diseases
Investigational molecules
Locations
Back to Slovakia80 clinical trials in Nitra, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
SlovakiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
SlovakiaStudy on the Effects of Eclitasertib in Adults with Moderate to Severe Ulcerative Colitis
SlovakiaStudy on Bowel Urgency in Adults with Moderate to Severe Ulcerative Colitis Treated with Mirikizumab
SlovakiaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
SlovakiaStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
SlovakiaStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
SlovakiaA study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia
SlovakiaA study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation
SlovakiaLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SlovakiaStudy of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)
SlovakiaComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on inflammatory bowel diseases, including studies of novel therapies for both Crohn's Disease and Ulcerative Colitis. Research evaluates treatments like obefazimod and risankizumab for managing moderate to severe cases.
Comprehensive research into cardiovascular diseases, examining new treatments for heart attacks, stroke prevention, and atherosclerosis. Studies include evaluation of medications like asundexian and inclisiran for various cardiac conditions.
Advanced trials in multiple sclerosis treatment, testing innovative therapies like frexalimab and remibrutinib. Research focuses on reducing relapse rates and improving long-term patient outcomes.
Studies examining treatments for chronic kidney disease and related conditions, including research on combination therapies with dapagliflozin and investigations into hypertriglyceridemia management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
